Cargando…

Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer

Ghrelin and obestatin are gastrointestinal peptides, encoded by the same preproghrelin gene. Both are expressed in breast cancer tissue and ghrelin has been implicated in breast cancer tumorigenesis. Despite recent advances in breast cancer management the need for new prognostic markers and potentia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grönberg, Malin, Ahlin, Cecilia, Naeser, Ylva, Janson, Eva Tiensuu, Holmberg, Lars, Fjällskog, Marie-Louise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395214/ https://www.ncbi.nlm.nih.gov/pubmed/28419141 http://dx.doi.org/10.1371/journal.pone.0176059

Ejemplares similares

Ghrelin expression is associated with a favorable outcome in male breast cancer
por: Grönberg, Malin, et al.
Publicado: (2018)

Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2
por: Papantoniou, Dimitrios, et al.
Publicado: (2020)

Nuclear osteopontin-c is a prognostic breast cancer marker
por: Zduniak, K, et al.
Publicado: (2015)

Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3
por: Ali, Abir Salwa, et al.
Publicado: (2020)

Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing’s syndrome
por: Lase, Ieva, et al.
Publicado: (2020)

Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort
por: Papantoniou, Dimitrios, et al.
Publicado: (2023)

High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers
por: Ahlin, Cecilia, et al.
Publicado: (2017)

The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer
por: Klintman, Marie, et al.
Publicado: (2013)

Therapeutic Potential of Targeting the Ghrelin Pathway
por: Colldén, Gustav, et al.
Publicado: (2017)

Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides
por: Aaltonen, K, et al.
Publicado: (2006)

Genome methylation patterns in male breast cancer – Identification of an epitype with hypermethylation of polycomb target genes
por: Johansson, Ida, et al.
Publicado: (2015)

Women Treated for Breast Cancer Experiences of Chemotherapy-Induced Pain: Memories, Any Present Pain, and Future Reflections
por: Hellerstedt-Börjesson, Susanne, et al.
Publicado: (2016)

Prognostic impact of the expression of Wnt-signaling proteins in cervical carcinoma FIGO stage I-IV treated with radiotherapy or chemoradiotherapy
por: Mordhorst, Louise Bohr, et al.
Publicado: (2016)

Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker
por: Johansson, Ida, et al.
Publicado: (2012)

Circulating Ghrelin Levels and Obestatin/Ghrelin Ratio as a Marker of Activity in Ulcerative Colitis
por: Jung, Ja Young, et al.
Publicado: (2015)

Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
por: Ali, Abir Salwa, et al.
Publicado: (2018)

Preclinical evidence of ghrelin as a therapeutic target in epilepsy
por: Ge, Tongtong, et al.
Publicado: (2017)

Design of the study: How can health care help female breast cancer patients reduce their stress symptoms? A randomized intervention study with stepped-care
por: Nordin, Karin, et al.
Publicado: (2012)

A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors
por: Dumanski, Jan P, et al.
Publicado: (2017)

Somatostatin receptor 1–5; expression profiles during rat development
por: Ludvigsen, Eva, et al.
Publicado: (2015)

The Role of Ghrelin and Ghrelin Signaling in Aging
por: Amitani, Marie, et al.
Publicado: (2017)

Targeting the Ghrelin Receptor as a Novel Therapeutic Option for Epilepsy
por: Buckinx, An, et al.
Publicado: (2021)

A Novel Human Ghrelin Variant (In1-Ghrelin) and Ghrelin-O-Acyltransferase Are Overexpressed in Breast Cancer: Potential Pathophysiological Relevance
por: Gahete, Manuel D., et al.
Publicado: (2011)

PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3
por: Ali, Abir Salwa, et al.
Publicado: (2020)

Leptin, ghrelin and calprotectin: inflammatory markers in childhood asthma?
por: Cobanoglu, Nazan, et al.
Publicado: (2013)

Serum inflammatory markers in obese mice: Effect of ghrelin
por: Khazaei, Majid, et al.
Publicado: (2015)

Malnutrition Markers and Serum Ghrelin Levels in Hemodialysis Patients
por: Montazerifar, Farzaneh, et al.
Publicado: (2014)

Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma
por: Ali, Abir Salwa, et al.
Publicado: (2017)

Concomitant Release of Ventral Tegmental Acetylcholine and Accumbal Dopamine by Ghrelin in Rats
por: Jerlhag, Elisabet, et al.
Publicado: (2012)

Effect of Ghrelin on Glucose-Insulin Homeostasis: Therapeutic Implications
por: Sangiao-Alvarellos, Susana, et al.
Publicado: (2010)

Ghrelin
por: Müller, T.D., et al.
Publicado: (2015)

DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma
por: Olsen, Thale Kristin, et al.
Publicado: (2022)

BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer
por: Bai, Jin, et al.
Publicado: (2013)

Insights into Orphan Nuclear Receptors as Prognostic Markers and Novel Therapeutic Targets for Breast Cancer
por: Aesoy, Reidun, et al.
Publicado: (2015)

Ghrelin and ghrelin receptor modulation of psychostimulant action
por: Wellman, Paul J., et al.
Publicado: (2013)

Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours
por: Söderquist, Fanny, et al.
Publicado: (2016)

Heterogeneity of Small Intestinal Neuroendocrine Tumors Metastasis: Biologic Patterns of a Series with Virchow’s Node Involvement
por: Wedin, Maria, et al.
Publicado: (2022)

Ghrelin and adipokines as circulating markers of disease activity in patients with Takayasu arteritis
por: Yilmaz, Hatice, et al.
Publicado: (2012)

Anxiolytic-Like Effects of Increased Ghrelin Receptor Signaling in the Amygdala
por: Jensen, Morten, et al.
Publicado: (2015)

MicroRNAs as prognostic markers and therapeutic targets in gliomas
por: Sufianov, Albert, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mgh8uov729kvdb55kab7d49tap